title: Bromodomains shake the hegemony of pan-acetyl antibodies.
abstract: Acetylation signaling pathways are involved in numerous cellular processes and are used as therapeutic targets in several disease contexts. However, acetylated proteins only represent a minor fraction of the full proteome, and the identification and quantification of acetylated sites remain a technological challenge. Currently, pan-acetyl antibodies are used to increase the abundance of acetylated peptides through affinity purification before MS analysis. These antibodies are powerful reagents, but they are hampered by a lack of specificity, affinity, and batch-to-batch reproducibility. In this issue, Bryson et al. (Proteomics 2015 15, 1470-1475) present an interesting alternative to these antibodies, in the form of bromodomains. These domains specifically recognize acetylated lysines, and were successfully used in this study to enrich for acetylated peptides before MS analysis. Future development of this pioneering approach could help overcome this limiting step in the characterization of acetylproteomes.
authors.affiliation: Institut National de la Recherche Médicale (Inserm), iRTSV-BGE, Grenoble, France; Université de Grenoble Alpes, iRTSV-BGE, Grenoble, France; Commissariat à l'Energie Atomique (CEA), iRTSV-BGE, Grenoble, France.
authors.forename: Morgane
authors.initials: M
authors.lastname: Champleboux
authors.forename: Jérôme
authors.initials: J
authors.lastname: Govin
mesh_terms: D000107:Acetylation; D000906:Antibodies / Q000737:chemistry*; D006801:Humans; D008239:Lysine / Q000032:analysis*; D013058:Mass Spectrometry / Q000379:methods; D017434:Protein Structure, Tertiary; D020543:Proteome / Q000737:chemistry*; D040901:Proteomics / Q000379:methods*
chemical_list: D000906:Antibodies; D020543:Proteome; D008239:Lysine
keywords: Acetylproteome; Antibody; Bromodomain; Lysine acetylation; Protein engineering; Technology
references.citation: Nat Rev Drug Discov. 2014 May;13(5):337-56
references.pmid: 24751816
references.citation: Mol Cell. 2013 May 9;50(3):444-56
references.pmid: 23583077
references.citation: Proteomics. 2013 Mar;13(6):910-31
references.pmid: 23404676
references.citation: Genes Cancer. 2012 May;3(5-6):353-61
references.pmid: 23226573
references.citation: Cell. 1992 Feb 7;68(3):561-72
references.pmid: 1346755
references.citation: Proteomics. 2015 May;15(9):1470-5
references.pmid: 25641834
references.citation: Amino Acids. 2012 Sep;43(3):1009-24
references.pmid: 22821267
references.citation: Biochim Biophys Acta. 2014 Dec;1839(12):1395-403
references.pmid: 24561874
references.citation: Mol Cell. 2013 Jun 6;50(5):723-35
references.pmid: 23707759
references.citation: Nature. 2015 Feb 5;518(7537):27-9
references.pmid: 25652980
references.citation: Nat Rev Mol Cell Biol. 2014 Aug;15(8):536-50
references.pmid: 25053359